Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H26N2O |
Molecular Weight | 370.4867 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N#CC1=CC2=C(OC3=C(C=CC=C3)C4=C2CCN(CC5CCCC5)CC4)C=C1
InChI
InChIKey=MUAHMQUPOQGKOQ-UHFFFAOYSA-N
InChI=1S/C25H26N2O/c26-16-19-9-10-25-23(15-19)21-12-14-27(17-18-5-1-2-6-18)13-11-20(21)22-7-3-4-8-24(22)28-25/h3-4,7-10,15,18H,1-2,5-6,11-14,17H2
Savoxepine (also known as cipazoxapine), a tetracyclic compound, possesses a potent neuroleptic-like effects. This compound acts via dopamine D(2)-receptor blockade. Savoxepine was studied in phase II clinical trials in Europe for the treatment of patients with psychotic disorders; however, these studied were discontinued.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Neuroleptic profile of cipazoxapine (Savoxepine), a new tetracyclic dopamine antagonist: clinical validation of the hippocampus versus striatum ratio model of dopamine receptors in animals. A preliminary report. | 1987 May |
|
Savoxepine: striatal dopamine-D2 receptor occupancy in human volunteers measured using positron emission tomography (PET). | 1993 |
|
Savoxepine fails to selectively influence glucose metabolism in the rat limbic system. | 1994 Mar |
|
Direct microtitre plate radioimmunoassay of savoxepine in unextracted plasma. | 1996 Feb |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2565583
In an open pilot-study 18 patients suffering from acute schizophrenic psychoses or paranoid syndromes were treated with savoxepine in an individually adapted dose range from 0.50 to 10 mg per day
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66883
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
13343J27CI
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
C152310
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
54359
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
SUB10461MIG
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
100000084101
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
DTXSID20229594
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105557
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
5907
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY | |||
|
79262-46-7
Created by
admin on Fri Dec 15 19:01:36 GMT 2023 , Edited by admin on Fri Dec 15 19:01:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)